Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Cancer Biologic Trials

Wisconsin

Cancer biologic therapy trials in Wisconsin

66 cancer biologic therapy studies are recruiting participants at sites in 56 cities across Wisconsin as of November 18, 2026, according to ClinicalTrials.gov.

Call (888) 343-5902
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Browse Wisconsin by city

Cities with the most studies recruiting right now.

Every Wisconsin city with a recruiting study

By research area: Lymphoma (25), Lung Cancer (18), Breast Cancer (12), Melanoma (4), Pancreatic Cancer (4), Prostate Cancer (3).

Milwaukee (41), Madison (34), La Crosse (26), Green Bay (25), Ashland (23), Marshfield (23), Stevens Point (23), Weston (22), Eau Claire (21), Sheboygan (20), Rice Lake (18), Minocqua (17), Mukwonago (17), Oconomowoc (17), Waukesha (17), Oshkosh (15), Sturgeon Bay (15), Burlington (14), Germantown (14), Grafton (14), Kenosha (14), Marinette (14), Racine (14), Summit (14), Wauwatosa (14), West Allis (14), Oconto Falls (13), Two Rivers (13), Appleton (12), Antigo (11), Wausau (11), Wisconsin Rapids (11), Rhinelander (10), Medford (9), Menomonee Falls (9), Oak Creek (9), West Bend (9), Cudahy (8), Neenah (8), New Berlin (8), New Richmond (8), Superior (7), Janesville (6), Johnson Creek (6), Spooner (6), Shawano (5), Berlin (4), New London (4), Waupaca (4), Brookfield (3), Chilton (3), Franklin (3), Hayward (3), Mequon (3), Greenfield (1), Hudson (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Breast cancer: recently updated in Wisconsin

Basic details from each study's public record (the 12 most recently updated of 66). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

    • Phase 2
    • All ages
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Appleton · Ashland · Berlin · and 33 more U.S. locations
    Registry record
    NCT05564377 · updated
  2. Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Madison
    Registry record
    NCT06393374 · updated
  3. A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Madison
    Registry record
    NCT06966700 · updated

Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Wisconsin on ClinicalTrials.gov.

Lung cancer: recently updated in Wisconsin

  1. Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Antigo · Ashland · Eau Claire · and 15 more U.S. locations
    Registry record
    NCT06498635 · updated
  2. Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Ashland · Green Bay · Menomonee Falls · and 8 more U.S. locations
    Registry record
    NCT07388524 · updated
  3. A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    La Crosse
    Registry record
    NCT07513376 · updated

Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Wisconsin on ClinicalTrials.gov.

Prostate cancer: recently updated in Wisconsin

  1. Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Ashland · Burlington · Eau Claire · and 21 more U.S. locations
    Registry record
    NCT03866382 · updated

Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Wisconsin on ClinicalTrials.gov.

Melanoma: recently updated in Wisconsin

  1. BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Ashland · Eau Claire · Green Bay · and 15 more U.S. locations
    Registry record
    NCT05136196 · updated

Source: ClinicalTrials.gov. Data processed . See every melanoma study recruiting in Wisconsin on ClinicalTrials.gov.

Lymphoma: recently updated in Wisconsin

  1. Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Eau Claire · Marshfield · Menomonee Falls · and 8 more U.S. locations
    Registry record
    NCT03739814 · updated
  2. Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

    • Phase 2
    • Up to 365 days
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Green Bay · Milwaukee
    Registry record
    NCT06317662 · updated
  3. Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Appleton · Ashland · Eau Claire · and 17 more U.S. locations
    Registry record
    NCT06337318 · updated

Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Wisconsin on ClinicalTrials.gov.

Pancreatic cancer: recently updated in Wisconsin

  1. Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Madison
    Registry record
    NCT05372614 · updated

Source: ClinicalTrials.gov. Data processed . See every pancreatic cancer study recruiting in Wisconsin on ClinicalTrials.gov.

Ask about studies in Wisconsin

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that test a biologic, such as a vaccine, an antibody, or a cell or gene therapy, as each study is coded in the registry.

Cancer Biologic Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 343-5902

or send a short form

How should we reach you?

Call